Cargando…
Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study
BACKGROUND: Anti-thymocyte globulin (ATG) as induction therapy in renal transplantation is facing the dilemma of reducing the incidence of acute rejection (AR) and delayed graft function (DGF) or increasing risks of infection and malignancy. The purpose of this study was to delineate the safety and...
Autores principales: | Liu, Hui-Ying, Cheng, Yuan-Tso, Luo, Hao Lun, Huang, Chiang-Chi, Chen, Chien Hsu, Shen, Yuan-Chi, Lee, Wen-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699478/ https://www.ncbi.nlm.nih.gov/pubmed/31440428 http://dx.doi.org/10.7717/peerj.7274 |
Ejemplares similares
-
Complications of rabbit anti-thymocyte globulin induction immunosuppression in HIV-infected kidney transplant recipients
por: Al Jurdi, Ayman, et al.
Publicado: (2022) -
Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs
por: Buddington, Randal K., et al.
Publicado: (2023) -
Optimal use of SGLT2 inhibitors in diabetic kidney transplant recipients
por: Pham, Phuong-Thu T., et al.
Publicado: (2022) -
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
por: Baron, Frédéric, et al.
Publicado: (2020) -
Severe Acute Interstitial Nephritis: Response to Therapy With Antithymocyte Globulin
por: Shao, Tiffany, et al.
Publicado: (2016)